False
July 7, 2025
Another Day Pharma tells us how a spider venom-derived topical peptide might be able to help those affected by erectile dysfunction and female sexual dysfunction.
11 min read
July 4, 2025
Following another appearance in our 2025 Power List, we discuss the journey of John Maher, co-founder and CSO, Leucid Bio, from Michel Sadelain’s New York lab to King’s College London.
5 min read
July 2, 2025
A new dual agonist GLP-1 is showing weight loss without gastrointestinal side effects and appetite suppression. We speak with the company to learn more.
3 min read
July 1, 2025
Since the FDA announced plans to phase out mandatory animal testing, in silico drug discovery and development platforms are emerging. Welcome to the age of biosimulation.
6 min read
June 30, 2025
We sit down with Audrey Greenberg to discuss investment, cell therapy, and what to look for when hiring talent.
6 min read
June 27, 2025
Researchers have developed a new way to create covalent peptide inhibitors of transcription factors – proteins once considered “undruggable.”
8 min read
June 25, 2025
Why spray-drying could reduce supply chain costs, address infrastructure challenges, and pave the way for intranasal mRNA vaccine delivery.
5 min read
June 25, 2025
Learning more about the people behind the Power List 2025.
5 min read
June 20, 2025
A new approach to tackling the blood-brain barrier is attracting attention from big pharma.
5 min read
By Stephanie Vine
June 12, 2025
There has been no new TB vaccine for over 100 years, but a candidate at the Gates Medical Research Institute in phase III has just finished enrolling the target of 20,000 participants.
10 min read
False